Daniel Joseph Oconnell
Director, Chief Executive Officer · 2 filings · Latest: Jan 21, 2026
Acumen Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ABOS | Daniel Joseph Oconnell | Director, Chief Executive Officer | Jan 22, 2026 | Sale | $1.88 | 2,689 | $5.1K | 881,275 | |
ABOS | Daniel Joseph Oconnell | Director, Chief Executive Officer | Jan 21, 2026 | Sale | $1.81 | 9,346 | $16.9K | 883,964 | |
ABOS | OConnell Daniel Joseph | — | Jan 22, 2026 | Proposed Sale | $1.88 | 2,689 | $5.1K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 21, 2026 | Proposed Sale | $1.81 | 9,346 | $16.9K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 12, 2026 | Proposed Sale | $1.73 | 5,388 | $9.3K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 9, 2026 | Proposed Sale | $1.76 | 12,941 | $22.8K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 8, 2026 | Proposed Sale | $1.82 | 8,143 | $14.8K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 7, 2026 | Proposed Sale | $1.99 | 37,755 | $75.0K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 6, 2026 | Proposed Sale | $1.97 | 5,102 | $10.0K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 5, 2026 | Proposed Sale | $1.97 | 4,649 | $9.2K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 21, 2025 | Proposed Sale | $1.59 | 12,619 | $20.1K | — | |
ABOS | OConnell Daniel Joseph | — | Jan 3, 2025 | Proposed Sale | $1.84 | 47,778 | $87.9K | — |